Comparison of therapeutic effects of bone marrow mesenchymal stem cell transplantation through pancreas peplos and vein in treatment of diabetes rats

Gao Feng,Zhou Han-xin,Qi Hui,Li Fu-rong

DOI: https://doi.org/10.3969/j.issn.1673-8225.2009.19.014

2009-01-01

Abstract:BACKGROUND:Present studies explored transdifferentiation and regulatory mechanism of bone marrow mesenchymal stem cells(BMSCs) after transplantation.Studies concerning methodology and function of stem cell transplantation for treating diabetes are rare.OBJECTIVE:To study the effects of different transplantation of BMSCs in diabetic model rats.DESING, TIME AND SETTING:The randomized controlled animal study was performed at the Clinical Research Center of Shenzhen People's Hospital from March to November 2008.MATERIALS:Four male Sprague Dawley rats aged 1 week were used for establishing BMSCs.Thirty-two female Sprague Dawley rats aged 8 weeks were equally and randomly divided into pancreas peplos transplantation group, vein transplantation group, diabetes control group, and normal control group.METHODS:Rat BMSCs were isolated and culture by the whole bone marrow method, and then purified and amplified by adherence.Rats in the pancreas peplos transplantation group, vein transplantation group and diabetes control group were abdominally injected with streptozotocin to establish diabetes models.Following model establishment, at the third passage of BMSCs at 5×106 was suspended into the 0.2 mL phosphate buffered saline, and multiply injected into pancreas peplos in the pancreas peplos transplantation group.In the vein transplantation group, rats were subjected to an equal volume of BMSC suspension via the vein.Rats in the diabetes control group and normal control group were left intact.MAIN OUTCOME MEASURES:Following transplantation, blood glucose, insulin, C-peptide level changes, and glucose tolerance were observed dynamically.RESULTS:Compared with diabetic control group, blood glucose value significantly decreased in the pancreas peplos transplantation group and vein transplantation group within 30 days following transplantation(P < 0.05), and the decrease range in the pancreas peplos transplantation group was mostly significant(P < 0.05).At 2, 4 and 6 days following transplantation, insulin and C-peptide levels significantly increased in the pancreas peplos transplantation group and vein transplantation group(P < 0.05), and the increase range was significant in the pancreas peplos transplantation group(P < 0.05), but still lower than in the normal control group(P < 0.05).Following intraperitoneal injection of glucose, blood glucose levels peaked at 30 minutes, decreased to fasting leveling at 90 minutes, and the glucose treatment ability was nearly to normal control group in the pancreas peplos transplantation group.The treatment ability to glucose in the vein transplantation group was slightly stronger compared with the diabetes control group(P < 0.05), but the levels did not reach a normal blood glucose level within 180 minutes in this two groups.CONCLUSION:Pathway of BMSC transplantation has direct relationship with treatment of diabetes.Pancreas peplos transplantation has better effects compared with the vein transplantation.